A new mRNA-based vaccine has been reportedly developed by scientists in Russia, which will be provided to patients for free by 2025.
The news was first shared by Andrey Kaprin, General Director of the Russian Ministry of Health's Radiology Medical Research Center, in an interview with Radio Rossiya.
As per Russia's TASS news agency, the vaccine was developed in collaboration with several research centers.
Earlier, Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology, said that the pre-clinical trials of the mRNA vaccine have shown positive data, demonstrating its ability to prevent tumor growth.
mRNA technology, used in COVID-19 vaccines, works by sending instructions to the body to replicate a small part of the virus so that the immune system could develop tools to fight the virus in the future.
Earlier this year, Russian President Vladimir Putin said in a televised comment, "We have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation."
Other than the latest announcement, Russia has been secretive about the various aspects of the vaccine development, including trial results, efficacy and dosage of vaccine, and the official name of the vaccine.
Due to the undisclosed facts, numerous scientists around the world remain skeptical about the actual possibility of the cancer vaccine.
"Until we see data from a clinical trial, there has to be skepticism about this," Professor Kingston Mills, a prominent immunologist at Trinity College Dublin, Ireland, told Newsweek.
"There's nothing in scientific journals that I can see about it. That's where you usually would start reading, as a scientist, about a breakthrough," Mills continued. "I don't see any paper about this, so I have nothing to go on in terms of what the science is."
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.